Background: Sickle cell disease is an autosomal recessive hereditary hemoglobinopathy. Patients with sickle cell disease (HbSS, Sβ, SC phenotypes) with permanent hemolytic anemia very often require transfusions. Objective: To describe the socio-demographic and clinical characteristics of polytransfused sickle cell patients in Kinshasa. Methods: This is a descriptive cross-sectional study of polytransfused sickle cell patients followed at the SS Anemia Mixed Medicine Center (CMMASS). Socio-demographic and clinical data were recorded on survey sheets. The parameters of interest were the district, age, gender, linguistic area, level of education, marital status, religion and place of screening for sickle cell disease, according to age of screening, weight, number of transfusion and the clinical signs of major sickle cell disease. Results: the median age of polytransfused sickle cell patients is 29 years. The female gender is in the majority at 51.1%. The majority of polytransfused sickle cell patients (32.2%) come from the Mont Amba district and are from the Greater Kasai area (34.4%). All polytransfused sickle cell patients are single. The majority have high school level (56.6%), are from revivalist churches (75.6%), and were first diagnosed with sickle cell disease at CMMASS (63.75%). The median age of screening was 13 years, the median number of transfusions is 24. Vaso-occlusive crisis is the main reason for consultation (77.7%). Conclusion: This study reveals that the median age of polytransfused sickle cell patients is 29 years. The majority of patients are female, single, from secondary school, praying in revival churches, from the district of Mont-Amba and from the Grand Kasaï area. Screening for sickle cell disease is done late, the median number of transfusions is 24. Vaso-occlusive crisis is the main reason for consultation for polytransfused sickle cell patients.
Cite this paper
Ilunga, A. K. K. , Kabengele, G. K. , Kilara, T. K. , Inkale, C. B. , Woto, I. T. , Makoka, S. K. , Kangite, G. Y. , Masikini, B. , Misengele, R. B. , Katuanda, C. M. , Vangu, C. P. , Bongenya, B. I. , Nyembue, D. T. and Kamangu, E. N. (2022). Sociodemographic Profile and Clinic of Polytransfused Sickle Cell Patients in Kinshasa: Case of the Center for Mixed Medicine and SS Anemia. Open Access Library Journal, 9, e9222. doi: http://dx.doi.org/10.4236/oalib.1109222.
Programme National de Lutte Contre la Drépanocytose (PNLCD), Ministere de Santé publique et Hygiene, Republique Democratique du Congo, avec l’appui de l’Organisation Mondiale de la Santé (OMS) (2016) Protocole National de Prise en Charge de la Drepanocytose en Republique Democratique du Congo. 2eme Edition.
Piel, F.B., Howes, R.E., Patil, A.P., et al. (2013) The Distribution of Haemoglobin C and Its Prevalence in Newborns in Africa. Scientific Reports, 3, Article No. 1671.
https://doi.org/10.1038/srep01671
World Health Organization (WHO) (1994) Guidelines for the Control of Haemoglobin Disorders. Hereditary Diseases Programme, World Health Organization, Geneva.
Kazadi, A.L., Ngiyulu, R.M., Gini-Ehungu, J.L., et al. (2019) The Clinical Characteristics of Congolese Children and Adolescents Suffering from Sickle-Cell Anemia Are Marked by the High Frequencies of Epistaxis Compared to Western Series. Pediatric Hematology and Oncology, 36, 267-276.
https://doi.org/10.1080/08880018.2017.1365397
Tshilolo, L., Amisi, L.M., Lukusa, D., et al. (2009) Neonatal Screening for Sickle Cell Anemia in Democratic Republic of Congo: Experience from a Pioneer Project on 31 204 Newborns. Journal of Clinical Pathology, 62, 35-38.
https://doi.org/10.1136/jcp.2008.058958
Piel, F.B., Steinberg, M.H. and Rees, D.C. (2017) Sickle Cell Disease. The New England Journal of Medicine, 377, 305. https://doi.org/10.1056/NEJMra1510865
Mwanaut, I., Bongenya, B., Bulanda, B., et al. (2019) Seroprevalence of HIV in Polytransfused Adult Sickle Cell Disease: Case of the Center of Mixed Medicine and SS Anemia of Kinshasa. ARC Journal of AIDS, 4, 18-21.
Ngo, S.F., Seck, M., Faya, B. and Diop, S. (2016) Morbidité et aspects évolutifs de la Drépanocytose SC: Une étude de 129 patients au service d’Hématologie Clinique de Dakar. Health Sciences, 17, 57-62.
Galacteros, F. (2001) Bases physiopathologiques de la drépanocytose, Prise en charge et actualités thérapeutiques. Bulletin de la Societe de Pathologie Exotique, 94, 77-79.
Shongo, M.Y.P., Mukuku, O., Lubala, T.K., et al. (2014) Drépanocytose chez l’enfant Lushois de 6 à 59 mois en phase stationnaire: épidémiologie et clinique. Pan African Medical Journal, 19, Article No. 71.
https://doi.org/10.11604/pamj.2014.19.71.3684
Nacoulma, E.W.C., Sakande, J., Kafando, E., et al. (2006) Profil hématologique et biochimique des drépanocytaires SS et SC en phase stationnaire au Centre Hospitalier National Yalgado Ouédraogo de Ouagadougou. Mali Medical, 21, 8-11.
Abdala, K.A., Mabiala, B. and Shindano, M.E. (2018) Aspects épidémiologiques, cliniques et thérapeutiques de la drépanocytose chez l’enfant à l’Hôpital général de référence de Kindu (HGRK). Revue Africaine de Médecine, 2, 81-87.
Mashako, M.R., Bitwe, R.M., Nsibu, C.N. and Mashako, Y.K. (2019) Profil épidémiologique et clinique de la drépanocytose à l’hôpital provincial du Nord-Kivu. La Revue Malgache de Pédiatrie, 2, 62-69.
Diagne, I., Ndiaye, O., Moreira, C., Stignate-Sy, H., Camara, B. and Diouf, S. (2000) Les syndromes drépanocytaires majeurs en Pédiatrie à Dakar (Sénégal). Archives de Pédiatrie, 7, 16-24. https://doi.org/10.1016/S0929-693X(00)88912-5
Mabiala, B., Nkanza, K.S.A.T., Ganza, Z.P.S., Nzingoula, S. and Senga, P. (2005) Causes d’hospitalisation des enfants drépanocytaires: Influence de l'age (CHU de Brazzaville, Congo). Bulletin de la Societe de Pathologie Exotique, 98, 392-393.
Dreux, O. (2012) Education thérapeutique pour les enfants drépanocytaires: Justifications à la mise en place et initiation de ce projet au CHU de Grenoble. Thèse de médecine, Université Joseph Fournier, Grenoble.
Nacoulma, E.W.C., Bonkoungou, P., Dembelele, Y.D. and Kam, L. (2006) Les drépanocytoses majeures dans le service de pédiatrie du centre hospitalier universitaire Sounou Sanon de Bobo-Dioulasso. Medecine d’Afrique Noire, 53, 694-698.
Tolo, A., Touré, A., N’dhatz, E., Nanho, D.C., Kouakou, B., Sanogo, I. and Sangare, A. (2006) Profil évolutif de la drépanocytose homozygote suivie: Expérience du service d’hématologie clinique du CHU de Yopougon. Medecine d’Afrique Noire, 53, 5-10.
Tshilolo, L. (2010) La drépanocytose en République Démocratique du Congo: Dépistage néonatal, profil génétique et hématologique. Thèse de médecine, Université Officielle de Mbuji-Mayi, Mbuji Mayi.
Kanange, M. and Mbayo, T. (2015) Les églises de réveil dans la ville de Lubumbashi: Fondements juridiques et application. Librairie Africaine d’Etudes Juridiques, 2, 341-357. https://doi.org/10.5771/2363-6262-2015-2-341
Mukinayi, B.M., Cibeyibeyi, G.K., Tumba, G.D. and Gulbis, B. (2018) Families Affected by Sickle Cell Disease: à Local Survey. The Pan African Medical Journal, 29, Article No. 24.
Mabiala, J.R., Nzingoula, S. and Senga, P. (2005) Les crises vaso-occlusives drépanocytaires chez l’enfant et l’adolescent à Brazzaville, Congo: Etude rétrospective de 587 cas. Bulletin de la Societe de Pathologie Exotique, 98, 365-370.
Mabiala, J.R., Pandzou, N. and Moyen, G. (2011) Les manifestations inaugurales de la drépanocytose au CHU de Brazzaville (Congo). Annals of African Medicine, 4, 711-717.